January 2015

New Product - Gallium Citrate Ga 67 Injection USP

Gallium Citrate Ga 67 Injection USP (gallium (Ga 67) citrate) may be useful in demonstrating the presence of the following malignancies: Hodgkins disease, lymphomas and bronchogenic carcinoma. Gallium (Ga 67) citrate is available as vials containing 244, 326, 488, and 733  MBq (74 MBq/mL) of radiation on calibration date.

This list is a summary of only some of the changes that have occurred over the last month. Before prescribing, always refer to the full product information.

Copyright © MIMS Australia Pty Ltd. All rights reserved.

MIMS Australia
Level 2, 1 Chandos Street
St Leonards NSW 2065
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au